Pneumococcal Polysaccharide Vaccine (PPSV23)

PPSV23 covers 23 strains of Streptococcus pneumoniae. It is recommended for adults 65+ and younger adults with chronic conditions such as diabetes, heart disease, lung disease, or immunosuppression.

The Pneumococcal Polysaccharide Vaccine (PPSV23) is recommended for 65 years and above; high-risk adults from 19 years. It falls under the Adult vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Pneumococcal Polysaccharide Vaccine (PPSV23) has an efficacy of 50–85% effective against invasive pneumococcal disease in adults. This means it provides significant protection against Pneumonia and Bacterial meningitis. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Redness; swelling; pain at injection site; mild fever. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Pneumococcal Polysaccharide Vaccine (PPSV23) should be avoided by: Severe allergic reaction to prior dose. Not for children under 2 years.. Always inform your healthcare provider of your full medical history before vaccination.

The Pneumococcal Polysaccharide Vaccine (PPSV23) typically costs ₹1,200–₹2,500 private in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.